The main market opportunities involve providing training and solutions for regulatory compliance and V&V best practices in regulated industries. This includes developing Master Validation Plans, ...
The life science industry faces opportunities in enhancing cGMP compliance by developing robust, risk-based Validation and Verification strategies. Training on creating effective Master Validation ...
The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...
Boston Cell Standards, Inc. (BCS), a private company bringing modern Quality tools and practices to Clinical Immunohistochemistry (IHC) testing worldwide, announced today that its IHC Reference ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
Medical Device Network on MSN
Merck KGaA and Remepy join forces to develop combo drug-digital therapies
The pair will develop drug-digital therapeutic combinations as a singular product, thus sidestepping reimbursement hurdles linked to individually approved digital therapies.
Environmental monitoring requirements in ATMP facilities, addressing regulatory compliance, GMP standards, and contamination ...
Validation documentation should define process parameters, monitoring strategies, and operating ranges that can support ...
Remepy, the pioneer of Hybrid Drugs, today announced a collaboration with Merck KGaA, Darmstadt Germany, a leading science and technology company, to explore the development of Hybrid Drugs across ...
Closed vs modular automation defines how high-throughput screening laboratories balance efficiency and flexibility. Closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results